Cargando…
N-Acetyl-Aspartyl-Glutamate in Brain Health and Disease
N-acetyl-aspartyl-glutamate (NAAG) is the most abundant dipeptide in the brain, where it acts as a neuromodulator of glutamatergic synapses by activating presynaptic metabotropic glutamate receptor 3 (mGluR3). Recent data suggest that NAAG is selectively localized to postsynaptic dendrites in glutam...
Autores principales: | Morland, Cecilie, Nordengen, Kaja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836185/ https://www.ncbi.nlm.nih.gov/pubmed/35163193 http://dx.doi.org/10.3390/ijms23031268 |
Ejemplares similares
-
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
por: Nguyen, Tu, et al.
Publicado: (2019) -
The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes
por: Kołodziejczyk, Karolina, et al.
Publicado: (2009) -
Dual role of N-acetyl-aspartyl-glutamate metabolism in cancer monitor and therapy
por: Asaka, Ryoichi, et al.
Publicado: (2019) -
Efficacy of N‐acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctivitis in an environmental exposure chamber
por: de Blay, Frédéric, et al.
Publicado: (2022) -
N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
por: Nagai, Takako, et al.
Publicado: (2014)